ADHD Archive — Page 1 of 1
-
November 7, 2013
Neurotransmitter’s role in bone balance
Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling. -
September 19, 2013
Transporter linked to autism risk
Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD). -
August 22, 2013
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. -
May 15, 2012
New clue to ADHD
A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD. -
April 6, 2012
Minds wide open: Neuroscience at Vanderbilt
Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience. -
November 2, 2011
Vanderbilt study finds no heart risk in ADHD medications
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.